Arena Pharmaceuticals rises after weight-loss drug deal with Eisai NASDAQ … to sell an anti-obesity and weight-loss drug called lorcaserin in the US The medication is still pending approval by the Food and Drug Administration. …
NPS Pharmaceuticals to Present at Citi Global Health Care Conference MarketWatch (press release) … MD, president and chief executive officer, is scheduled to present at the 2010 Citi Global Health Care Conference in New York on Thursday, May 27, … Community Health Systems to Participate in Citi Investment Research 2010 …MarketWatch (press release) Spectranetics to Present at the Citi Global Health Care Conference on May 27MarketWatch (press release) MEDNAX to Present at 2010 Citi Investment Research Global Health Care ConferenceMarketWatch (press release) MarketWatch (press release) -MarketWatch (press release) -MarketWatch (press release) all 355 news articles »
King Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Health… MarketWatch (press release) … May 13, 2010, at 1:00 pm ET at the Bank of America Merrill Lynch 2010 Health Care Conference at the Grand Hyatt Hotel in New York, New York. … Odyssey HealthCare to Present at Bank of America Merrill Lynch Health Care …MarketWatch (press release) Baxter to Present at the Bank of America Merrill Lynch Health Care ConferenceMarketWatch (press release) LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2010 …MarketWatch (press release) MarketWatch (press release) -MarketWatch (press release) -MarketWatch (press release) all 167 news articles »
Arena Pharmaceuticals posts narrower 4Q loss BusinessWeek The drugmaker said it studied more than 7000 patients who were treated for up to two years, and subjects showed significant weight loss in both trials. … Arena will launch lorcaserin with partner or aloneReuters Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial …PR Newswire (press release) Arena Pharmaceuticals Q4 Loss Narrows – UpdateRTT News FierceBiotech -PR-USA.net (press release) all 45 news articles »
Arena Pharmaceuticals posts narrower 4Q loss Forbes The drugmaker said it studied more than 7000 patients who were treated for up to two years, and subjects showed significant weight loss in both trials. … Arena will launch lorcaserin with partner or aloneReuters Arena Pharmaceuticals Q4 Loss Narrows – UpdateRTT News Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial …PR Newswire (press release) FierceBiotech all 35 news articles »
Arena Pharmaceuticals' weight loss drug lorcaserin gets FDA review CanadianBusiness.com SAN DIEGO (AP) – Federal regulators are reviewing Arena Pharmaceuticals' application for a weight-loss drug, the biotechnology company said Wednesday. … Arena Pharmaceuticals Announces FDA Acceptance of Lorcaserin NDA for FilingPR Newswire (press release) Market Report — In Play (ARNA)MSN Money
The 2 sidebars have been placed within an element so that you can enter information here at the bottom or up at the top that exists outside the 2 sidebars.
Powered by Yahoo! Answers
This site is protected with Urban Giraffe's plugin 'HTML Purified' and Edward Z. Yang's . 24935 items have been purified.